We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

Hope For Children’s Rare Drug Approval Process

USA Today (Kaiser Health News), June 7, 2015. A reward program is an extension of the 21st Century Cures bill, which seeks to rewrite the rules for drug development to make innovative treatments available faster.

FDA Reviewing Safety of Essure Birth Control Implant

The Associated Press, June 25, 2015. Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

House Overwhelmingly Passes Bill to Speed FDA Drug Approvals

The Washington Post, July 10, 2015. The bill’s laundry list of provisions that tweak the process for approving new drugs or devices have raised significant concern from industry watchdogs and physicians who say the legislation is aimed more at helping drug and device companies than patients.

21st Century Cures Drug Bill Triggers a DC Dust-Up Over Relaxed Development Regs

Fierce Biotech, July 10, 2015. Lawmakers in the House easily passed the 21st Century Cures Act today, a big step toward once again shaking up the legal framework built to guide drug development in the U.S. while significantly boosting the amount of funding that flows to the NIH. Consumer advocates, though, see the new development regulations as a recipe for unleashing drugs and devices that would later prove dangerous and unhelpful.

House Passes ‘Cures’ Bill to Hasten Drugs to Market

Medscape, July 10, 2015. The House of Representatives overwhelmingly passed a bipartisan bill designed to speed up the development and approval of new drugs and medical devices. “The bill greatly benefits the pharmaceutical industry [and] medical device manufacturers,” said Diana Zuckerman.